Guardion Health Sciences, Inc. (GHSI)

8.07 +0.15 (+1.89%) At close: 04:00PM EDT

Guardion Health Sciences, Inc.

2925 Richmond Avenue
Suite 1200
Houston, TX 77098
United States
800 873 5141
https://www.guardionhealth.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 9

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Robert Neal Weingarten	Independent Chairman & Secretary	79k	N/A	1952
Mr. Craig J. Sheehan	Chief Commercial Officer	256.88k	N/A	1971
Ms. Janet Hall	President & CEO	N/A	N/A	1959
Ms. Katie Cox	Chief Accounting Officer	N/A	N/A	1970

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported nutrition, medical foods, and dietary supplements in North America and Europe, and Internationally. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. It develops ImmuneSF, a nutraceutical formulation, as well as a portfolio of nutraceutical products under the NutriGuard brand. Further, it distributes medical foods products through e-commerce in an online store, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.

Corporate governance

Guardion Health Sciences, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.